A medical incident in Andhra Pradesh has resulted in the death of one student and the hospitalization of more than 50 others. The individuals affected had reportedly been administered chloroquine, an antiparasitic medication commonly used to treat malaria. The drug functions by increasing heme levels in the blood, which is toxic to the malaria parasite.

While the incident has prompted concern, specific details regarding the context of the medication's administration—such as whether it was part of a state-run health drive, a school-based program, or an individual medical decision—remain limited. Health officials have begun an inquiry to determine if the adverse reactions were caused by improper dosage, pre-existing health conditions, or potential issues with the medication supply itself. At this stage, there is no official confirmation on the exact cause of the student's death, and medical teams are monitoring the condition of those currently hospitalized to ensure they receive necessary care. Further updates are expected as local health departments conclude their initial investigations into the distribution protocols followed at the site of the incident.